IO Informatics recently announce the launch of IO Healthcare, “an extension of the company’s award winning life sciences platform, Sentient, into precision medicine applications including biomarker discovery, clinical trial optimization and decision support. By adding clinical, genomic, metabolic and proteomic information to the platform’s existing repository of public resources, IO Healthcare enables the earlier application of clinical information to enhance research and development.”

Robert Stanley, IO Informatics President and CEO commented, “Since 2003, IO has been addressing research informatics needs at pharmaceutical and biotech companies with our semantic technology platform… Now, with IO Healthcare, we directly address the challenges of taking molecular data into clinical applications to realize the promise of precision medicine… With the growing availability and decreasing cost to integrate and query data from genomics and other molecular biology and clinical applications, IO Healthcare is a natural extension for both our Sentient platform and our customers, who have been using IO in their research for many years.”

The article also notes, “The Company’s semantic framework makes it possible to apply patterns including content from patient records and phenotypic information such as gene, protein and metabolic variables relevant across all stages of research, from early stage experimentation to precision medicine.”

Image: Courtesy IO Informatics